Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New fenofibrate products launched in Japan for hyperlipidemia

Dec. 21, 2011

Merck & Co. synthesizes new PRCP inhibitors

Dec. 21, 2011

Scientists at Mitsubishi Tanabe Pharma disclose new GPR119 receptor agonists

Dec. 21, 2011

New dipeptidyl peptidase 4 inhibitors patented by Chinese company

Dec. 21, 2011

FDA does not require REMS program for Korlym in Cushing's syndrome

Dec. 20, 2011

Isis Pharmaceuticals provides update on NDA submission for mipomersen sodium

Dec. 19, 2011

Array BioPharma patents new GPR119 receptor agonists

Dec. 19, 2011

Novel PRCP inhibitors discovered at Merck & Co.

Dec. 19, 2011

BioSante Pharmaceuticals reports new phase III LibiGel data

Dec. 19, 2011

Catabasis raises additional funding for CAT-2003 development in hypertriglyceridemia

Dec. 16, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...